237 related articles for article (PubMed ID: 3995346)
1. Muscarinic cholinergic receptors in human infant forebrain: [3H]quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sections.
Johnston MV; Silverstein FS; Reindel FO; Penney JB; Young AB
Brain Res; 1985 Apr; 351(2):195-203. PubMed ID: 3995346
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem.
Kinney HC; Panigrahy A; Rava LA; White WF
J Comp Neurol; 1995 Nov; 362(3):350-67. PubMed ID: 8576444
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of muscarinic cholinergic receptors in the developing human fetal brain: regional distribution and characterization.
Gremo F; Palomba M; Marchisio AM; Marcello C; Mulas ML; Torelli S
Early Hum Dev; 1987 May; 15(3):165-77. PubMed ID: 3608889
[TBL] [Abstract][Full Text] [Related]
4. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex.
Ravikumar BV; Sastry PS
J Neurochem; 1985 Jan; 44(1):240-6. PubMed ID: 3964831
[TBL] [Abstract][Full Text] [Related]
9. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
10. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization of GABAergic and muscarinic cholinergic receptor sites in the visual system of the kitten.
Skangiel-Kramska J; Cymerman U; Kossut M
Acta Neurobiol Exp (Wars); 1986; 46(2-3):119-30. PubMed ID: 3022561
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic cholinergic receptors in canine adrenal gland.
Tobin JR; Breslow MJ; Traystman RJ
Am J Physiol; 1992 Oct; 263(4 Pt 2):H1208-12. PubMed ID: 1415769
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]-QNB and [3H]-pirenzepine.
Wamsley JK; Gehlert DR; Roeske WR; Yamamura HI
Life Sci; 1984 Apr; 34(14):1395-402. PubMed ID: 6546776
[TBL] [Abstract][Full Text] [Related]
14. Quantitative autoradiography of muscarinic and benzodiazepine receptors in the forebrain of the turtle, Pseudemys scripta.
Schlegel JR; Kriegstein AR
J Comp Neurol; 1987 Nov; 265(4):521-9. PubMed ID: 2828438
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of muscarinic receptors in the rat brain with emphasis on the differentiation of M1- and M2-subtypes--semi-quantitative in vitro autoradiography.
Miyoshi R; Kito S; Shimizu M; Matsubayashi H
Brain Res; 1987 Sep; 420(2):302-12. PubMed ID: 3676763
[TBL] [Abstract][Full Text] [Related]
17. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
Watson M; Vickroy TW; Fibiger HC; Roeske WR; Yamamura HI
Brain Res; 1985 Nov; 346(2):387-91. PubMed ID: 3840399
[TBL] [Abstract][Full Text] [Related]
18. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
20. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
